Ticlopidine

Ticlopidine Basic information
Product Name:Ticlopidine
Synonyms:2-c)pyridine,4,5,6,7-tetrahydro-5-((2-chlorophenyl)methyl)-thieno(;5-((2-Chlorophenyl)methyl)-4,5,6,7-tetrahydrothieno(3,2-c)pyridine;5-(O-Chlorobenzyl)-4,5,6,7-tetrahydrothieno-[3,2-c]pyridine;PCR 5332;pcr5332;Thieno(3,2-c)pyridine, 4,5,6,7-tetrahydro-5-((2-chlorophenyl)methyl)-;Thieno[3,2-c]pyridine, 5-[(2-chlorophenyl)methyl]-4,5,6,7-tetrahydro-;5-(2-CHLORO-BENZYL)-4,5,6,7-TETRAHYDRO-THIENO[3,2-C]PYRIDINE
CAS:55142-85-3
MF:C14H14ClNS
MW:263.79
EINECS:259-498-5
Product Categories:
Mol File:55142-85-3.mol
Ticlopidine Structure
Ticlopidine Chemical Properties
Melting point 210-212 °C
Boiling point 117-120 °C(Press: 0.5 Torr)
density 1.273±0.06 g/cm3(Predicted)
storage temp. 2-8°C(protect from light)
solubility Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
pka7.10±0.20(Predicted)
form Solid
color Off-White to Pale Yellow
CAS DataBase Reference55142-85-3(CAS DataBase Reference)
NIST Chemistry ReferenceThieno[3,2-c]pyridine, 5-[(2-chlorophenyl)methyl]-4,5,6,7-tetrahydro-(55142-85-3)
EPA Substance Registry SystemThieno[3,2-c]pyridine, 5-[(2-chlorophenyl)methyl]-4,5,6,7-tetrahydro- (55142-85-3)
Safety Information
MSDS Information
Ticlopidine Usage And Synthesis
OriginatorTiclid,Millot,France,1978
UsesTiclopidine suppresses aggregation of thrombocytes and possesses antiaggregant activity. It is believed that its action is connected to its effect on thrombocyte membranes and the reduction in quantity of released adenosine diphosphate and serotonin, which facilitate aggregation of thrombocytes. In wide-ranging clinical trials, ticlopidine presented a number of advantages compared to aspirin.
UsesTiclopidine is an antiplatelet drug for the treatment of ischemic heart diseases.
DefinitionChEBI: A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Manufacturing ProcessA solution of thieno[3,2-c]pyridine (13.5 g; 0.1 mol) and 2-chlorobenzyl chloride (17.7 g) in acetonitrile (150 ml) is boiled during 4 hours. After evaporation of the solvent, the solid residue consists of 5-(2- chlorobenzyl)-thieno[3,2-c]pyridinium chloride which melts at 166°C (derivative n° 30). This compound is taken up into a solution comprising ethanol (300 ml) and water (100 ml). Sodium borohydride (NaBH4)(20 g) is added portionwise to the solution maintained at room temperature. The reaction medium is maintained under constant stirring during 12 hours and is then evaporated. The residue is taken up into water and made acidic with concentrated hydrochloric acid to destroy the excess reducing agent. The mixture is then made alkaline with ammonia and extracted with ether. The ether solution is washed with water, dried and evaporated. The oily residue is dissolved in isopropanol (50 ml) and hydrochloric acid in ethanol solution is then added thereto.
After filtration and recrystallization from ethanol, there are obtained 5-(2- chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine hydrochloride crystals (yield: 60%) having a melting point (Koefler block) of 190°C.
Brand name4-c-32 53-32-c;Aplaquette;Derivatives;Klodin;Opteron;Panaldine;Tcp;Ticlidan;Ticlodix;Ticlodone;Ticlopedine;Ticlosan;Tiklid;Tiklyd;Tilcid.
Therapeutic FunctionPlatelet aggregation inhibitor
World Health Organization (WHO)Ticlopidine, an inhibitor of platelet aggregation, was introduced in 1978 for use as an antithrombotic agent. By 1982 its use had been associated with cases of agranulocytosis, severe leucopenia and impaired haemostasis. The drug remains available in most countries in which it was approved with appropriate warnings in the product information.
General DescriptionTiclopidine, 5-[(2-chlorophenyl)methyl]-4,5,6,7-tetrahydrothieno [3,2-c]pyridine hydrochloride(Ticlid), is useful in reducing cardiac events in patients withunstable angina and cerebrovascular events in secondaryprevention of stroke. It belongs to the thienopyridine classand facilitated the development of clopidogrel. One of thedrawbacks to this agent is its side effect profile, whichincludes neutropenia, and patients receiving this antithromboticshould have their blood levels monitored. Its mechanismof action is similar to that of clopidogrel, in that itinhibits the purinergic receptors on platelets.
SynthesisTiclopidine, 5-(o-chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine (24.2.1), is synthesized in many different ways. The first way consists of N-alkylation of 4,5,6,7-tetrahydrothieno[3,2-c]pyridine with 2-chlorobenzylchloride.

Synthesis_55142-85-3

4,5,6,7-Tetrahydrothieno[3,2-c]pyridine TICLOPIDINE,TICLOPIDINE HCL,TICLOPIDINE HYDROCHLORIDE,Ticlopidine HCl ( EDMF /COS) TICLOPIDINE IMPURITY A Benzyl chloride Benzylchloromethyl ether 2-Chloro-5-chloromethylpyridine Pizotifen Cephaloridine Hydrochlorothiazide Enalapril/maleate Ticlopidine TICLOPIDINE HYDROCHLORIDE IMP. D (EP) AS HYDROCHLORIDE: 5-BENZYL-4,5,6,7-TETRAHYDROTHIENO[3,2-C]PYRIDINE HYDROCHLORIDE Clopidol TICLOPIDINE HYDROCHLORIDE IMP. C (EP) AS HYDROCHLORIDE: (2-CHLOROPHENYL)METHANAMINE HYDROCHLORIDE Ticlopidine Benzyl chloroformate Pyridine PIPERACILLIN Tetrahydrothiophene

Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.